William Li Net Worth

William Li biography

Dr. William W. Li M.D. serves as Independent Director of the Company. He has served as a member of our Board since January 2017. Dr. Li is a co-founder of the Angiogenesis Foundation in Cambridge, Massachusetts, of which he has been the President since April 2000 and Medical Director since December 1994. Dr. Li has extensive expertise in the field of angiogenesis and its therapeutic development and clinical applications. He trained with Dr. Judah Folkman, who pioneered the field of angiogenesis research. Through the Angiogenesis Foundation, Dr. Li has worked in association with the National Institutes of Health, and other major governmental and academic institutions and industry leaders on angiogenesis-related programs. Dr. Li received his M.D. degree from University of Pittsburgh School of Medicine. He completed his clinical training in internal medicine at the Massachusetts General Hospital in Boston. Dr. Li has also served on the faculties of Harvard Medical School, Tufts University School of Veterinary Medicine and Dartmouth Medical School.

How old is William Li?

William Li is 57, he's been the Independent Director of Leap Therapeutics Inc since 2017. There are 6 older and 4 younger executives at Leap Therapeutics Inc. The oldest executive at Leap Therapeutics Inc is James Cavanaugh, 82, who is the Independent Director.

What's William Li's mailing address?

William's mailing address filed with the SEC is C/O LEAP THERAPEUTICS, INC., 47 THORNDIKE STREET SUITE B1-1, CAMBRIDGE, MA, 02141.

Insiders trading at Leap Therapeutics Inc

Over the last 8 years, insiders at Leap Therapeutics Inc have traded over $0 worth of Leap Therapeutics Inc stock and bought 10,810,588 units worth $40,517,079 . The most active insiders traders include Advisors Llcperceptive Life..., Christopher Mirabelli, eLtd. Bei Gene,. On average, Leap Therapeutics Inc executives and independent directors trade stock every 142 days with the average trade being worth of $1,990,710. The most recent stock trade was executed by Christopher Mirabelli on 26 January 2024, trading 5,000 units of LPTX stock currently worth $13,850.

What does Leap Therapeutics Inc do?

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.

Leap Therapeutics Inc executives and stock owners

Leap Therapeutics Inc executives and other stock owners filed with the SEC include:

• Douglas Onsi,
  President, Chief Executive Officer, Director
• Augustine Lawlor,
  Chief Operating Officer
• Christopher Mirabelli,
  Chairman of the Board
• Cynthia Sirard,
  Chief Medical Officer
• Mark O'Mahony,
  Chief Manufacturing Officer
• Nissim Mashiach,
  Independent Director
• Joseph Loscalzo,
  Independent Director
• William Li,
  Independent Director
• Thomas Dietz,
  Lead Independent Director
• James Cavanaugh,
  Independent Director
• Monica Bertagnolli,
  Independent Director
• John W Littlechild,
  Director
• Ventures Ix, L.P.Healthcare...,
  
• Harold R Werner,
  10% owner
• Lilly & Co Eli,
  10% owner
• Patricia A. Martin,
  Director
• Christian M Richard,
  Director
• Richard Schilsky,
  Director
• Advisors Llcperceptive Life...,
  
• Ventures Viii, L.P.Health C...,
  
• Jason Baum,
  Chief Scientific Officer
• Christine Granfield,
  VP, Head of Reg Affairs/Qual
• Ltd. Bei Gene,,
  10% owner